Company: THC
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000070318-25-000009
Chunk: 217

Company: TENET HEALTHCARE CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 5
Chunk 217
---
 of 1934, as amended (the “Exchange Act”), or incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

30

Table of Contents

At December 31, 201920202021202220232024Tenet Healthcare Corporation$100.00 $105.00 $214.80 $128.29 $198.71 $331.92 S&P 500$100.00 $118.40 $152.39 $124.79 $157.59 $197.02 S&P Health Care$100.00 $113.45 $143.09 $140.29 $143.18 $146.87 Peer Group$100.00 $109.05 $164.16 $150.73 $174.12 $203.85 

Repurchases of Common Stock—In July 2024, our board of directors authorized the repurchase of up to $1.500 billion of our common stock through a share repurchase program that has no expiration date. Repurchases under the program may be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities laws and regulations. The share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended for periods or discontinued at any time. We had no share repurchase transactions during the three months ended December 31, 2024 (not including shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee or director equity awards). The maximum dollar value of shares that may yet be purchased under the program is $1.376 billion.